Product Information
DRONABINOL 5 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $3.3535 per EA under NDC 00904714504. Its NADAC has been published 219 times since Dec 15, 2021.
FDA first approved this application on May 31, 1985. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904714504
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DRONABINOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA018651FDA Approved
5/31/1985
TE Code
AB
On Market Since
3/3/2021
Pharmacological Classes
Price Statistics
The NADAC for DRONABINOL 5 MG CAPSULE has been published 219 times since Dec 15, 2021, and over the history we have for it it has risen 38.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3535 per EA |
|---|---|
| All-time high | $3.3535 (Sep 30, 2026) |
| All-time low | $1.8485 (Jun 21, 2023) |
| 52-week high | $3.3535 |
| 52-week low | $2.9465 |
| Median price | $2.7763 |
| Average price | $2.6733 |
| Largest weekly change | +43.4% (Oct 18, 2023) |
| Weeks tracked | 219 |
| Tracking since | Dec 15, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dronabinol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cannabinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DRONABINOL 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DRONABINOL 5 MG CAPSULE, manufactured by Major Pharmaceuticals, is $3.3535 per EA (NDC 00904714504), effective Sep 30, 2026.
How has the price of DRONABINOL 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DRONABINOL 5 MG CAPSULE has risen 38.3%. It has been tracked across 219 weekly CMS publications since Dec 15, 2021.
What are the highest and lowest recorded NADAC prices for DRONABINOL 5 MG CAPSULE?
Since Dec 15, 2021, the NADAC for DRONABINOL 5 MG CAPSULE has ranged from a low of $1.8485 (Jun 21, 2023) to a high of $3.3535 (Sep 30, 2026), with a median of $2.7763 per EA.
Are there cheaper alternatives to DRONABINOL 5 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DRONABINOL 5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DRONABINOL 5 MG CAPSULE?
DRONABINOL 5 MG CAPSULE (NDC 00904714504) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.